Search

The FDA has authorized Armata Pharmaceuticals to initiate a phase 1b/2a clinical trial, which they are calling "SWARM-P.a.", to test AP-PA02, its lead phage cocktail candidate, against Pseudomonas aeruginosa airway infections in cystic fibr

Vivek Mutalik (Lawrence Berkeley National Lab) and colleagues published their method of high-throughput mapping of the phage resistance landscape in E. coli in PLoS Biology. Sound familiar? We highlighted this paper's corresponding preprint

As there is currently no gold standard for developing a phage cocktail, Melissa Haines (University of Leicester, UK) and colleagues set out to describe a novel approach to phage cocktail development by comparing different methods side by si

Before now, only eight phages and two archaeal viruses had been isolated from deep sea vents. Sarah Thiroux (Université de Bretagne Occidentale, France) and colleagues published a new paper describing another: the first head‐tailed virus in

Eveline-Marie Lammens (KU Leuven) and colleagues published a new perspective in Nature Communications that explores the synthetic biology potential of phages for engineering non-model bacteria.

PHAVES #10 will be a seminar by Dr. Paul Jaschke, Assistant Professor at Macquarie University, Australia, on Nov. 10, 5:30 PM Eastern Time (GMT-4) / Nov. 11 at 9:30 AM AEST. His talk is entitled "Learning How to Engineer Genomes by Building

PHAVES #10 will be a seminar by Dr. Paul Jaschke, Assistant Professor at Macquarie University, Australia, on Nov. 10, 5:30 PM Eastern Time (GMT-4) / Nov. 11 at 9:30 AM AEST. His talk is entitled "Learning How to Engineer Genomes by Building

The phage research community sadly lost one of its greats this month; Dr. Richard Calendar passed away on October 10 following a long battle with prostate cancer. Rich, as he was known to many, was a renowned UC Berkeley Professor of Molec

It's World Phage Week (Oct 22-28)! Check out Twitter (#WorldPhageWeek) for lots of fun posts from the global phage community showcasing fun phage facts, great phage images and art, favourite papers, exciting milestones and more.

The Ibadan Bacteriophage Research Team (IBRT) is hosting a series of webinars Oct 26-27 to celebrate World Phage Week! Theme: "Early Career Research in Bacteriophage Studies: A leverage for Bacteriophage Therapy Advancement". Speakers: Prof

Dr. Jason Gill (Center for Phage Technology, Texas A&M) and Dr. Paul Turner (Yale University) will discuss their work on phage therapy to treat drug resistant bacterial infections in a free webinar hosted by The Scientist on Oct 29 from 2:3

The Ibadan Bacteriophage Research Team is hosting a series of webinars to celebrate International Phage Week at the end of the month! Talks will take place Oct 26 and 27. The theme will be "Early Career Research in Bacteriophage Studies: A

Proteon Pharmaceuticals is hosting a webinar Oct 28 (16:30 to 17:30 IST) on E. coli phages to treat poultry flocks. Register here.

I am looking for a collaborative research grant under INDIA-EU Cooperation on research & innovation Green Deal: Building a low-carbon, climate resilient future sponsored by Department of Biotechnology, New Delhi. I would like to develop pha

Frontiers in Cellular and Infection Microbiology has a new research topic open, The Application of Phages Against Infectious Diseases. Editors: Pan Tao, Jeremy Barr, Jingmin Gu.

Ever wondered about the biological function of genes that overlap with other genes? Bradley Wright (Macquarie University, Australia) and colleagues engineered the gene overlaps out of the φX174 phage genome and found that gene overlap was c

Charles Bernard (CNRS, France) and colleagues published a new paper in the ISME Journal describing their identification of a new communication system that may regulate host defense mechanisms (similar to the arbitrium system) in Bacillus ph

Emma Guerin and Colin Hill (APC Microbiome Ireland and University College Cork) published a new review on human gut phages in Frontiers in Cellular and Infection Microbiology. They discuss the main human gut phageome findings to date (incl.

Sensei Biotherapeutics has raised $28.5 million to advance their pipeline of personalized cancer drugs, one of which is an immunophage therapy that involves engineering lambda phage to display tumor-associated antigens, leading activated T

UMass is expanding its SEA-PHAGES undergraduate phage hunting program, with a goal of eventually replacing its traditional intro biology lab course with the SEA-PHAGES curriculum for all 1,200 students who participate each academic year.